122 related articles for article (PubMed ID: 2857357)
21. Thalidomide makes a comeback.
Dodd-Butera T; Broderick M
RN; 2003 May; 66(5):32-5; quiz 36. PubMed ID: 12778690
[No Abstract] [Full Text] [Related]
22. Successful treatment of orogenital ulceration with transdermal nicotine patches.
Kanekura T; Kanzaki T
Br J Dermatol; 1999 Dec; 141(6):1140-1. PubMed ID: 10722271
[No Abstract] [Full Text] [Related]
23. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
Connolly M; Armstrong JS; Buckley DA
Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
[No Abstract] [Full Text] [Related]
24. [The advances of thalidomide in oral mucosal uses].
Shi J; Ji XD; Chen QM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Nov; 39(6):525-7. PubMed ID: 15854333
[No Abstract] [Full Text] [Related]
25. Thalidomide: current therapeutic uses and management of its toxicities.
Tariman JD
Clin J Oncol Nurs; 2003; 7(2):143-7. PubMed ID: 12696209
[TBL] [Abstract][Full Text] [Related]
26. A cautious comeback for thalidomide.
Harv Health Lett; 1998 Feb; 23(4):4-5. PubMed ID: 9516304
[No Abstract] [Full Text] [Related]
27. Thalidomide.
Med Lett Drugs Ther; 1998 Oct; 40(1038):103-4. PubMed ID: 9813597
[No Abstract] [Full Text] [Related]
28. [Current use of thalidomide].
Revuz J
Ann Dermatol Venereol; 1990; 117(4):313-21. PubMed ID: 2195968
[No Abstract] [Full Text] [Related]
29. [Mouth and pharyngeal hyperalgesic syndromes in AIDS].
Gehanno P; Barry B; Depondt J; Guedon C; Poignonec S; Leport C; Gorin I
Ann Otolaryngol Chir Cervicofac; 1990; 107(5):311-3. PubMed ID: 2221724
[TBL] [Abstract][Full Text] [Related]
30. [Genital malformations in thalidomide-damaged girls (author's transl)].
Hoffmann W; Grospietsch G; Kuhn W
Geburtshilfe Frauenheilkd; 1976 Dec; 36(12):1066-70. PubMed ID: 1010296
[TBL] [Abstract][Full Text] [Related]
31. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
Robertson LP; Hickling P
Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
[No Abstract] [Full Text] [Related]
32. Thalidomide, drug safety and early drug regulation in the UK.
Shah RR
Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):199-255. PubMed ID: 11770171
[No Abstract] [Full Text] [Related]
33. Longterm clinical remission of oral and cutaneous pemphigus with thalidomide.
Lee FC
Int J Dermatol; 2011 Sep; 50(9):1120-3. PubMed ID: 22126875
[No Abstract] [Full Text] [Related]
34. Thalidomide in AIDS: one institution's response to the challenge of an experimental protocol.
Killip T; Harlow N
J Am Med Womens Assoc (1972); 1994; 49(4):122-3. PubMed ID: 7930352
[No Abstract] [Full Text] [Related]
35. Thalidomide approved.
Posit Aware; 1998; 9(5):16. PubMed ID: 11365882
[TBL] [Abstract][Full Text] [Related]
36. Two congenital neurological abnormalities caused by thalidomide.
Murphy R; Mohr P
Br Med J; 1977 Nov; 2(6096):1191. PubMed ID: 589081
[No Abstract] [Full Text] [Related]
37. Thalidomide effective in treating AIDS-related mouth ulcers.
AIDS Patient Care STDS; 1996 Feb; 10(1):51. PubMed ID: 11361666
[No Abstract] [Full Text] [Related]
38. Thalidomide and cranial nerve abnormalities.
Phelps PD; Roland PE
Br Med J; 1977 Dec 24-31; 2(6103):1672. PubMed ID: 589412
[No Abstract] [Full Text] [Related]
39. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
Hegarty A; Hodgson T; Porter S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):576-85. PubMed ID: 12738949
[TBL] [Abstract][Full Text] [Related]
40. [Fetal thalidomide syndrome].
Muto R; Ohashi H
Ryoikibetsu Shokogun Shirizu; 2001; (33):700-1. PubMed ID: 11462641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
